Literature DB >> 793467

The Jake Walk Blues. A toxicologic tragedy mirrored in American popular music.

J P Morgan, T C Tulloss.   

Abstract

In 1930 thousands of cases of muscle pain, weakness of upper and lower extremities, and minimal sensory impairment occurred in the United States. The illness was caused by the consumption of an adulterated Jamaica ginger extract ("Jake"), an illicit beverage then popularly used in the southern and midwestern United States to circumvent prohibition statutes. The additive tri-ortho-cresyl phosphate caused severe, only partially reversible damage to the spinal cord and peripheral nervous tissue. Victims with resultant gait impairment, sometimes permanent, were said to have the "Jake Leg" or "Jake Walk." Twelve commercial phonographic recordings made between 1928 and 1934 by southern rural artists, white and black, refer to Jake or Jake-induced infirmity. These reveal preepidemic cultural familiarity with Jake, and the later, postepidemic performances reflect a whimsical, even cynical, cultural attitude that those with "Jake Leg" were suffering the wages of sin and should not be regarded as objects of pity or sympathy.

Entities:  

Mesh:

Year:  1976        PMID: 793467     DOI: 10.7326/0003-4819-85-6-804

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  6 in total

1.  Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS.

Authors:  Darryl Johnson; Melissa D Carter; Brian S Crow; Samantha L Isenberg; Leigh Ann Graham; H Akin Erol; Caroline M Watson; Brooke G Pantazides; Marcel J van der Schans; Jan P Langenberg; Daan Noort; Thomas A Blake; Jerry D Thomas; Rudolph C Johnson
Journal:  J Mass Spectrom       Date:  2015-04       Impact factor: 1.982

2.  Sentinel Health Events (occupational): a basis for physician recognition and public health surveillance.

Authors:  D D Rutstein; R J Mullan; T M Frazier; W E Halperin; J M Melius; J P Sestito
Journal:  Am J Public Health       Date:  1983-09       Impact factor: 9.308

3.  Neuropathy target esterase gene mutations cause motor neuron disease.

Authors:  Shirley Rainier; Melanie Bui; Erin Mark; Donald Thomas; Debra Tokarz; Lei Ming; Colin Delaney; Rudy J Richardson; James W Albers; Nori Matsunami; Jeff Stevens; Hilary Coon; Mark Leppert; John K Fink
Journal:  Am J Hum Genet       Date:  2008-02-28       Impact factor: 11.025

4.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03

5.  Activation of Neuregulin 1/ErbB Signaling Is Involved in the Development of TOCP-Induced Delayed Neuropathy.

Authors:  Hai-Yang Xu; Pan Wang; Ying-Jian Sun; Ming-Yuan Xu; Li Zhu; Yi-Jun Wu
Journal:  Front Mol Neurosci       Date:  2018-04-23       Impact factor: 5.639

6.  Epidemics and outbreaks of peripheral nervous system disorders: II. Toxic and nutritional causes.

Authors:  Stéphane Mathis; Antoine Soulages; Jean-Michel Vallat; Gwendal Le Masson
Journal:  J Neurol       Date:  2020-09-11       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.